Cellular Origins

Constellation® is an automated cell therapy manufacturing platform that enables scalable, flexible production without therapy redevelopment or comparability risk.

Health and bio Manufacturing and industrial

Latest funding

$40M Series A · January 1, 2026

Source: fundraisingfox.com

Funding history ↓

Website: cellularorigins.com.

LinkedIn: cellularorigins.

Categories: Health and bio Manufacturing and industrial.

Stage: Series A.

Last round: Jan 1, 2026 · 315 days ago.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredAug 17, 2021 (5 years old)

Funding rounds

January 1, 2026
Series A · $40M
Source: fundraisingfox.com
August 17, 2021
Website created

Companies like Cellular Origins

CCellaresSeries B+ · Jul 2026
OOri Biotech$100M Series B+ · Jan 2022
LLimula$6.8M Seed · Jun 2024
RRESONIKSSeed · May 2026
BBioOra$16.84M Series A · Oct 2026
SStämmSeries A · Mar 2022

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cellular-origins (get a free API key).